Your browser doesn't support javascript.
loading
Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.
Zhou, J; Luo, J; Wu, K; Yun, E-J; Kapur, P; Pong, R-C; Du, Y; Wang, B; Authement, C; Hernandez, E; Yang, J; Xiao, G; Cha, T-L; Wu, H-C; Wu, D; Margulis, V; Lotan, Y; Brugarolas, J; He, D; Hsieh, J-T.
Afiliação
  • Zhou J; Department of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
  • Luo J; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Wu K; Department of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Yun EJ; Department of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
  • Kapur P; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Pong RC; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Du Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Wang B; Department of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
  • Authement C; Department of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
  • Hernandez E; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Yang J; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Xiao G; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Cha TL; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Wu HC; Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China, Taiwan.
  • Wu D; Department of Urology, China Medical University Hospital, Taichung, Republic of China, Taiwan.
  • Margulis V; Department of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
  • Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Brugarolas J; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • He D; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Hsieh JT; Department of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
Oncogene ; 35(35): 4663-74, 2016 09 01.
Article em En | MEDLINE | ID: mdl-26876207
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Resistencia a Medicamentos Antineoplásicos / Proteínas Ativadoras de ras GTPase / Proliferação de Células / Serina-Treonina Quinases TOR Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Resistencia a Medicamentos Antineoplásicos / Proteínas Ativadoras de ras GTPase / Proliferação de Células / Serina-Treonina Quinases TOR Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China